CD8A and melanoma: In addition to the well-documented CD4+ and CD8+ T-cell subsets, another peripheral subset of T-cells, expressing the neural cell adhesion molecule 1 (NCAM1; CD56), commonly expressed on group I innate lymphoid NK-cells[13,14], has been relatively poorly investigated in the context of melanoma immunotherapy.